Urologic Disorders

Aug 15, 2012 Issue
Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms [Clinical Evidence Handbook]

What are the effects of medical, herbal, and surgical treatments in men with BPH?

Jul 1, 2012 Issue
American Urological Association Approach to the Diagnosis and Management of IC/BPS [Practice Guidelines]

The American Urological Association has published recommendations aimed at guiding physicians in recognizing interstitial cystitis/bladder pain syndrome (IC/BPS), conducting a valid diagnostic process, and treating patients by maximizing symptom control and minimizing adverse effects.

Jul 1, 2011 Issue
Hormone Therapy for Postmenopausal Women with Urinary Incontinence [FPIN's Clinical Inquiries]

Postmenopausal women should not receive oral hormone therapy for treatment of urinary incontinence.

May 15, 2011 Issue
Interstitial Cystitis/Painful Bladder Syndrome [Article]

Interstitial cystitis/painful bladder syndrome affects more than 1 million persons in the United States, but the cause remains unknown. Most patients with interstitial cystitis/painful bladder syndrome are women with symptoms of suprapubic pelvic and/or genital area pain, dyspareunia, urinary urgenc...

Mar 15, 2010 Issue
Stress Incontinence [Clinical Evidence Handbook]

What are the effects of surgical and nonsurgical treatments for women with stress incontinence?

Aug 1, 2008 Issue
Radiologic Evaluation of Hematuria: Guidelines from the American College of Radiology's Appropriateness Criteria [Article]

Hematuria, symptomatic and incidental, that involves more than three red blood cells per high-power field on two of three properly collected urinalysis specimens warrants some type of imaging to evaluate the upper tracts. Traditionally, excretory urography or the intravenous pyelogram has been the m...

Mar 1, 2008 Issue
Urinary Retention in Adults: Diagnosis and Initial Management [Article]

Urinary retention is the inability to voluntarily void urine. This condition can be acute or chronic. Causes of urinary retention are numerous and can be classified as obstructive, infectious and inflammatory, pharmacologic, neurologic, or other. The most common cause of urinary retention is benign ...

Dec 15, 2006 Issue
Newer Agents for the Management of Overactive Bladder [Article]

The anticholinergics tolterodine and oxybutynin are well established in the management of overactive bladder. However, their activity at muscarinic receptors distant from the target site (i.e., bladder) produces anticholinergic side effects leading to poor tolerability. In 2004, trospium, solifenaci...

May 15, 2006 Issue
Assessment of Microscopic Hematuria in Adults [Article]

Microscopic hematuria, a common finding on routine urinalysis of adults, is clinically significant when three to five red blood cells per high-power field are visible. Etiologies of microscopic hematuria range from incidental causes to life-threatening urinary tract neoplasm. The lack of evidence-ba...

Jan 1, 2006 Issue
Anticholinergic Drugs for Overactive Bladder [Cochrane for Clinicians]

Tolterodine (Detrol) is as effective as immediate-release oxybutynin (Ditropan) and causes less dry mouth. A dose of 1 mg tolterodine twice daily is as effective as higher dosages of tolterodine. Extended-release preparations have less risk of dry mouth but are more expensive.

Pages: Previous 1 2 3 4 5 Next

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now